Consistent with clinical findings, experiments on RCC cell lines demonstrated that, on the one hand, PROX1 overexpression dramatically enhanced proliferation and migration of RCC cells in vitro, and on the other hand, PROX1 depletion significantly inhibited proliferation and migration of RCC cells in vitro. Here, PROX1 is linked to renal cell carcinoma.